Hostname: page-component-76fb5796d-wq484 Total loading time: 0 Render date: 2024-04-26T08:22:13.163Z Has data issue: false hasContentIssue false

A single nucleotide polymorphism in SLC1A1 gene is associated with age of onset of obsessive-compulsive disorder

Published online by Cambridge University Press:  15 April 2020

S. Dallaspezia*
Affiliation:
Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy
M. Mazza
Affiliation:
Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy
C. Lorenzi
Affiliation:
Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy
F. Benedetti
Affiliation:
Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy
E. Smeraldi
Affiliation:
Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy
*
*Corresponding author. Istituto Scientifico Ospedale San Raffaele, Department of Clinical Neurosciences, San Raffaele Turro, Via Stamira d’Ancona 20, Milano, Italy. Tel.: +39 2 264 331 56; fax: +39 2 264 332 65. E-mail address:dallaspezia.sara@hsr.it (S. Dallaspezia).
Get access

Abstract

Different genetic polymorphisms in the SLC1A1 have been shown to be associated with obsessive-compulsive disorder. Rs301430 is a T/C functional polymorphism affecting the gene expression and extrasynaptic glutamate concentration.We observed that Rs301430 influence age at onset in obsessive-compulsive disorder.

Type
Short communications
Copyright
Copyright © Elsevier Masson SAS 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arnold, P.D., Sicard, T., Burroughs, E., Richter, M.A., Kennedy, J.L.Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 2006;63:769776.CrossRefGoogle ScholarPubMed
Benedetti, F., Bernasconi, A., Lorenzi, C., Pontiggia, A., Serretti, A., Colombo, C.et al.A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 2004;355:3740.CrossRefGoogle ScholarPubMed
Benedetti, F., Bollettini, I., Barberi, I., Radaelli, D., Poletti, S., Locatelli, C.et al.Lithium and GSK3-beta promoter gene variants influence white matter microstructure in bipolar disorder. Neuropsychopharmacology 2013;38:313327.CrossRefGoogle ScholarPubMed
Chakrabarty, K., Bhattacharyya, S., Christopher, R., Khanna, S.Glutamatergic dysfunction in OCD. Neuropsychopharmacology 2005;30:17351740.CrossRefGoogle ScholarPubMed
Danbolt, N.C.Glutamate uptake. Prog Neurobiol 2001;65:1105.CrossRefGoogle ScholarPubMed
Dickel, D.E., Veenstra-VanderWeele, J., Cox, N.J., Wu, X., Fischer, D.J., Van Etten-Lee, M.et al.Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 2006;63:778785.CrossRefGoogle ScholarPubMed
do Rosario-Campos, M.C., Leckman, J.F., Curi, M., Quatrano, S., Katsovitch, L., Miguel, E.C.et al.A family study of early-onset obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2005;136B:9297.CrossRefGoogle ScholarPubMed
Hanna, G.L., Veenstra-VanderWeele, J., Cox, N.J., Boehnke, M., Himle, J.A., Curtis, G.C.et al.Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 2002;114:541552.CrossRefGoogle ScholarPubMed
Hudziak, J.J., Van Beijsterveldt, C.E., Althoff, R.R., Stanger, C., Rettew, D.C., Nelson, E.C.et al.Genetic and environmental contributions to the Child Behavior Checklist Obsessive-Compulsive Scale: a cross-cultural twin study. Arch Gen Psychiatry 2004;61:608616.CrossRefGoogle ScholarPubMed
Kanai, Y., Hediger, M.A.The glutamate/neutral amino acid transporter family SLC1: molecular, physiological and pharmacological aspects. Pflugers Arch 2004;447:469479.CrossRefGoogle ScholarPubMed
Lafleur, D.L., Pittenger, C., Kelmendi, B., Gardner, T., Wasylink, S., Malison, R.T.et al.N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology (Berl) 2006;184:254256.CrossRefGoogle ScholarPubMed
Lahiri, D.K., Nurnberger, J.I.J.A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res 1991;19:5444.CrossRefGoogle Scholar
Narayanaswamy, J.C., Viswanath, B., Veshnal Cherian, A., Bada Math, S., Kandavel, T., Janardhan Reddy, Y.C.Impact of age of onset of illness on clinical phenotype in OCD. Psychiatry Res 2012;200:554559.CrossRefGoogle ScholarPubMed
Nestadt, G., Samuels, J., Riddle, M., Bienvenu, O.J., Liang, K.Y., LaBuda, M.et al.A family study of obsessive-compulsive disorder. 3rd Arch Gen Psychiatry 2000;57:358363.CrossRefGoogle ScholarPubMed
Nieoullon, A., Canolle, B., Masmejean, F., Guillet, B., Pisano, P., Lortet, S.The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?. J Neurochem 2006;98:10071010.CrossRefGoogle Scholar
Pittenger, C., Kelmendi, B., Wasylink, S., Bloch, M.H., Coric, V.Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up. J Clin Psychopharmacol 2008;28:363367.CrossRefGoogle ScholarPubMed
Rosenberg, D.R., MacMaster, F.P., Keshavan, M.S., Fitzgerald, K.D., Stewart, C.M., Moore, G.J.Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000;39:10961100.CrossRefGoogle ScholarPubMed
Samuels, J., Wang, Y., Riddle, M.A., Greenberg, B.D., Fyer, A.J., McCracken, J.T.et al.Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2011;156B:472477.CrossRefGoogle ScholarPubMed
Smeraldi, E., Benedetti, F., Zanardi, R.Serotonin transporter promoter genotype and illness recurrence in mood disorders. Eur Neuropsychopharmacol 2002;12:7375.CrossRefGoogle ScholarPubMed
Stewart, S.E., Fagerness, J.A., Platko, J., Smoller, J.W., Scharf, J.M., Illmann, C.et al.Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2007;144B:10271033.CrossRefGoogle ScholarPubMed
Stewart, S.E., Jenike, E.A., Hezel, D.M., Stack, D.E., Dodman, N.H., Shuster, L.et al.A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. J Clin Psychopharmacol 2010;30:3439.CrossRefGoogle ScholarPubMed
Stewart, S.E., Mayerfeld, C., Arnold, P.D., Crane, J.R., O’Dushlaine, C., Fagerness, J.A.et al.Meta-analysis of association between obsessive-compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B Neuropsychiatr Genet 2013;162B:367379.CrossRefGoogle ScholarPubMed
Ting, J.T., Feng, G.Glutamatergic synaptic dysfunction and obsessive-compulsive disorder. Curr Chem Genomics 2008;2:6275.CrossRefGoogle ScholarPubMed
Wang, X., Cui, D., Wang, Z., Fan, Q., Xu, H., Qiu, J.et al.Cross-sectional comparison of the clinical characteristics of adults with early-onset and late-onset obsessive-compulsive disorder. J Affect Disord 2012;136:498504.CrossRefGoogle ScholarPubMed
Wendland, J.R., Moya, P.R., Timpano, K.R., Anavitarte, A.P., Kruse, M.R., Wheaton, M.G.et al.A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry 2009;66:408416.CrossRefGoogle ScholarPubMed
Willour, V.L., Yao Shugart, Y., Samuels, J., Grados, M., Cullen, B., Bienvenu, O.J.et al.Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am J Hum Genet 2004;75:508513.CrossRefGoogle ScholarPubMed
Wu, K., Hanna, G.L., Rosenberg, D.R., Arnold, P.D.The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav 2012;100:726735.CrossRefGoogle ScholarPubMed
Wu, H., Wang, X., Xiao, Z., Yu, S., Zhu, L., Wang, D.et al.Association between SLC1A1 gene and early-onset OCD in the Han Chinese population: a case-control study. J Mol Neurosci 2013;50:353359.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.